{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:08:46Z","timestamp":1722888526229},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1996,6,1]],"date-time":"1996-06-01T00:00:00Z","timestamp":833587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1996,6]]},"DOI":"10.1007\/bf01806211","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T19:31:35Z","timestamp":1119900695000},"page":"161-169","source":"Crossref","is-referenced-by-count":4,"title":["Does induction chemotherapy with a mitoxantrone\/vinorelbine regimen allow a breast-conservative treatment in patients with operable locoregional breast cancer?"],"prefix":"10.1007","volume":"40","author":[{"given":"Antoine","family":"Adenis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Vanlemmens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Hecquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Bonneterre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf the French Northern Oncology Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01806211_CR1","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1097-0142(19881215)62:12<2507::AID-CNCR2820621210>3.0.CO;2-D","volume":"62","author":"GN Hortobagyi","year":"1988","unstructured":"Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, Mac Neese RN, Paulus D, Holmes FA, Romsdahl MM, Fraschini G, Mac Bride CM, Martin RG, Montague E: Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 62: 2507\u20132516, 1988","journal-title":"Cancer"},{"key":"BF01806211_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/1097-0142(19900701)66:1<119::AID-CNCR2820660122>3.0.CO;2-3","volume":"66","author":"C Jacquillat","year":"1990","unstructured":"Jacquillat C, Weil M, Baillet F, Borel C, Auclerc G, de Maublanc MA, Housset M, Forget G, Thill L, Soubrane C, Khayat D: Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 66: 119\u2013129, 1990","journal-title":"Cancer"},{"key":"BF01806211_CR3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0959-8049(92)90145-R","volume":"28A","author":"E B\u00e9lembaogo","year":"1992","unstructured":"B\u00e9lembaogo E, Feillel V, Chollet P, Cur\u00e9 H, Verrelle P, Kwiatkowski F, Achard JL, Le Bouedec G, Chassagne J, Bignon YJ, de Latour M, Lafaye C, Dauplat J: Neoadjuvant chemotherapy in 126 operable breast cancer. Eur J Cancer 28A: 896\u2013900, 1992","journal-title":"Eur J Cancer"},{"key":"BF01806211_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910550102","volume":"55","author":"G Bonnadonna","year":"1993","unstructured":"Bonnadonna G: From adjuvant to neo-adjuvant chemotherapy in high-risk breast cancer: the experience of the Milan Cancer Institute. Steimer Award lecture 1992. Int J Cancer 55: 1\u20134, 1993","journal-title":"Int J Cancer"},{"key":"BF01806211_CR5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/oxfordjournals.annonc.a057953","volume":"2","author":"L Mauriac","year":"1991","unstructured":"Mauriac L, Durand M, Avril A, Dilhuydy JM: Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Ann Oncol 2: 347\u2013354, 1991","journal-title":"Ann Oncol"},{"key":"BF01806211_CR6","first-page":"592","volume":"29A","author":"IE Smith","year":"1993","unstructured":"Smith IE, Jones AI, O'Brien MER, Mc Kinna JA, Sacks N, Baum M. Primary medical (neoadjuvant) chemotherapy for operable breast cancer. Eur J Cancer 29A: 592\u2013595, 1993","journal-title":"Eur J Cancer"},{"key":"BF01806211_CR7","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/1097-0142(19940815)74:4<1283::AID-CNCR2820740417>3.0.CO;2-S","volume":"74","author":"G Calais","year":"1994","unstructured":"Calais G, Berger C, Descamps P, Chapet S, Reynaud-Bougnoux A, Body G, Bougnoux P, Lansac J, Le Floch O: Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 74: 1283\u20131288, 1994","journal-title":"Cancer"},{"key":"BF01806211_CR8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0959-8049(94)90537-1","volume":"30A","author":"SM Scholl","year":"1994","unstructured":"Scholl SM, Fourquet A, Asselain B, Pierga JY, Vilcoq JR, Durand JC, Dorval T, Palangi\u00e9 T, Jouve M, Beuzeboc P, Garcio-Giralt E, Salmon RJ, de la Rochefordi\u00e8re A, Campana F, Pouillart P: Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6, Eur J Cancer 30A: 645\u2013652, 1994","journal-title":"Eur J Cancer"},{"key":"BF01806211_CR9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1200\/JCO.1995.13.2.424","volume":"13","author":"IE Smith","year":"1995","unstructured":"Smith IE, Walsh G, Jones A, Prendiville J, Johnston S, Gusterson B, Ramage F, Robertshaw H, Sacks N, Ebbs S, Mc Kinna JA, Baum M: High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. J Clin Oncol 13: 424\u2013429, 1995","journal-title":"J Clin Oncol"},{"key":"BF01806211_CR10","first-page":"1727","volume":"63","author":"JH Goldie","year":"1979","unstructured":"Goldie JH, Coldman A: A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727\u20131733, 1979","journal-title":"Cancer Treat Rep"},{"key":"BF01806211_CR11","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/0277-5379(91)90408-6","volume":"27","author":"JM Kurtz","year":"1991","unstructured":"Kurtz JM: Should surgery remain the initial treatment of operable breast cancer? Eur J Cancer 27: 1539\u20131542, 1991","journal-title":"Eur J Cancer"},{"key":"BF01806211_CR12","first-page":"374","volume-title":"Cancer: principles and practice of oncology","author":"BA Chabner","year":"1993","unstructured":"Chabner BA, Myers CE: Antitumor Antibiotics. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology (ed 4). Philadelphia, PA, Lippincott, 1993, pp 374\u2013384","edition":"ed 4"},{"key":"BF01806211_CR13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0277-5379(84)90215-3","volume":"6","author":"RE Coleman","year":"1984","unstructured":"Coleman RE, Maisey MN, Knight RK, Rubens RD: Mitoxantrone in advanced breast cancer: a phase II study with special attention to cardiotoxicity. Eur J Cancer Clin Oncol 6: 771\u2013776, 1984","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01806211_CR14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0140-6736(90)90277-C","volume":"335","author":"AL Harris","year":"1990","unstructured":"Harris AL, Cantwell BMJ, Carmichael J, Wilson R, Farndon J, Dawes P, Ghani S, Evans RGB: Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer. Lancet 335: 186\u2013190, 1990","journal-title":"Lancet"},{"key":"BF01806211_CR15","first-page":"1021","volume":"70","author":"KS Wilson","year":"1986","unstructured":"Wilson KS, Paterson AHG: First-line mitoxantrone chemotherapy for advanced brast cancer. Cancer Treat Rep 70: 1021\u20131022, 1986","journal-title":"Cancer Treat Rep"},{"key":"BF01806211_CR16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00174161","volume":"3","author":"HT Mouridsen","year":"1985","unstructured":"Mouridsen HT, Cornbleet M, Stuart-Harris R, Smith I, Coleman R, Rubens R, McDonald M, Rainer H, van Oosterom A, Smyth J: Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study. Invest New Drugs 3: 139\u2013148, 1985","journal-title":"Invest New Drugs"},{"key":"BF01806211_CR17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/jnci\/83.15.1077","volume":"83","author":"JD Cowan","year":"1991","unstructured":"Cowan JD, Neidhart JA, McClure S, Coltman CA, Gumbart C, Martino S, Hutchins LF, Stephens RL, Vaughan CB, Osborne CK: Randomized trial of doxorubicin bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group Study. J Natl Cancer Inst 83: 1077\u20131084, 1991","journal-title":"J Natl Cancer Inst"},{"key":"BF01806211_CR18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1200\/JCO.1986.4.5.672","volume":"4","author":"JA Neidhart","year":"1986","unstructured":"Neidhart JA, Gochnour D, Roach R, Hoth D, Young D: A comparison of mitoxantrone and doxorubicin in breast cancer. J Clin Oncol 4: 672\u2013677, 1986","journal-title":"J Clin Oncol"},{"key":"BF01806211_CR19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1200\/JCO.1989.7.5.560","volume":"7","author":"IC Henderson","year":"1989","unstructured":"Henderson IC, Allegra JC, Woodcock T, Wolff S, Bryan S, Cartwright K, Dukart G, Henry D: Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer. J Clin Oncol 7: 560\u2013571, 1989","journal-title":"J Clin Oncol"},{"key":"BF01806211_CR20","first-page":"715","volume":"30A","author":"P Pouillart","year":"1994","unstructured":"Pouillart P, Foll\u00e9zou JY, Palangie T, Feuilhade F, George C, Richard E: Long-term results of a randomized trial comparing regimens of cyclophosphamide and fluorouracil with either mitoxantrone or doxorubicin in patients with advanced breast cancer. Eur J Cancer 30A: 715\u2013716, 1994","journal-title":"Eur J Cancer"},{"key":"BF01806211_CR21","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.1988.6.10.1611","volume":"6","author":"JM Bennett","year":"1988","unstructured":"Bennett JM, Muss HB, Doroshow JH, Wolff S, Krementz ET, Cartwright K, Dukart G, Reisman A, Schoch I: A randomized multicenter trial comparing mitoxantrone, cyclophosphamide and 5-fluorouracil and doxorubicin, cyclophosphamide and 5-fluorouracil in the therapy of metastatic breast cancer. J Clin Oncol 6: 1611\u20131620, 1988","journal-title":"J Clin Oncol"},{"key":"BF01806211_CR22","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1200\/JCO.1993.11.7.1245","volume":"11","author":"P Fumoleau","year":"1993","unstructured":"Fumoleau P, Delgado FM, Delozier T, Monnier A, Gil Delgado MA, Kerbrat P, Garcia-Giralt E, Keiling R, Namer M, Closon MT, Goudier MJ, Chollet P, Lecourt L, Montcuquet P: Phase II trial of weekly intravenous vinorelbine in firstline advanced breast cancer chemotherapy. J Clin Oncol 11: 1245\u20131252, 1993","journal-title":"J Clin Oncol"},{"key":"BF01806211_CR23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/oxfordjournals.annonc.a058873","volume":"5","author":"M Degardin","year":"1994","unstructured":"Degardin M, Bonneterre J, Hecquet B, Pion JM, Adenis A, Horner D, Demaille A: Vinorelbine (Navelbine) as a salvage treatment for advanced breast cancer. Ann Oncol 5: 423\u2013426, 1994","journal-title":"Ann Oncol"},{"key":"BF01806211_CR24","unstructured":"Spielmann M, Brain E, Sari C: Salvage chemotherapy (CT) with combination of mitoxantrone (MTZ) and vinorelbine (VNR) in resistant to anthracyclines advanced breast cancer (ABC). Fourth International Congress on Neoadjuvant Chemotherapy, Paris, France, February 2\u20135, 1993 (abstr 14)"},{"key":"BF01806211_CR25","first-page":"202","volume":"82","author":"JM Ferrero","year":"1995","unstructured":"Ferrero JM, Pivot X, Namer M, Wendling JL, Frenay M, Francois E, Hoch M, Teissier E: Mitoxantrone-vinorelbine as first line chemotherapy in metastatic breast cancer. Bull Cancer 82: 202\u2013207, 1995","journal-title":"Bull Cancer"},{"key":"BF01806211_CR26","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1200\/JCO.1994.12.9.1764","volume":"12","author":"M Spielmann","year":"1994","unstructured":"Spielmann M, Dorval T, Turpin F, Antoine E, Jouve M, MayLevin F, Lacombe D, Rouesse J, Pouillart P, Tursz T, Merle S: Phase II trial of vinorelbine-doxorubicin as first-line therapy of advanced breast cancer. J Clin Oncol 12: 1764\u20131770, 1994","journal-title":"J Clin Oncol"},{"key":"BF01806211_CR27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkeler A: Reporting results of cancer treatment. Cancer 47: 207\u2013214, 1981","journal-title":"Cancer"},{"key":"BF01806211_CR28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.1995.13.3.547","volume":"13","author":"TJ Powles","year":"1995","unstructured":"Powles TJ, Hickish TF, Makris A, Ashley SE, O'Brien MER, Tidy VA, Casey S, Nash AG, Sacks N, Cosgrove D, Mac Vicar D, Fernando I, Ford HT: Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 13: 547\u2013552, 1995","journal-title":"J Clin Oncol"},{"key":"BF01806211_CR29","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1200\/JCO.1993.11.12.2370","volume":"11","author":"B Quesnel","year":"1993","unstructured":"Quesnel B, Kantarjian H, Bjergaard JP, Brault P, Estey E, Lai JL, Tilly H, Stoppa AM, Archimbaud E, Harousseau JL, Bauters F, Fenaux P: Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8; 16): a report on 25 cases and review of the literature. J Clin Oncol 11: 2370\u20132379, 1993","journal-title":"J Clin Oncol"},{"key":"BF01806211_CR30","unstructured":"Ragaz J, Aird R, Goldie J, Coldman A, Lee N, Worth A: (Preoperative neoadjuvant) therapy for breast cancer. Early results of the northamerican studies. International Symposium on Neoadjuvant treatment of Surgical Breast carcinoma. Madrid, 3\/25\/1994 (abstract)"},{"key":"BF01806211_CR31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.1995.13.3.537","volume":"13","author":"B Fisher","year":"1995","unstructured":"Fisher B: Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. J Clin Oncol 13: 537\u2013540, 1995","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01806211\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:43:52Z","timestamp":1557402232000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01806211"}},"subtitle":["A French Northern Oncology Group trial in 105 patients"],"short-title":[],"issued":{"date-parts":[[1996,6]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,6]]}},"alternative-id":["BF01806211"],"URL":"https:\/\/doi.org\/10.1007\/bf01806211","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[1996,6]]}}}